Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Comorbid Chronic Illness and the Diagnosis and Treatment of Depression in Safety Net Primary Care Settings

Chizobam Ani, Mohsen Bazargan, David Hindman, Douglas Bell, Michael Rodriguez and Richard S. Baker
The Journal of the American Board of Family Medicine March 2009, 22 (2) 123-135; DOI: https://doi.org/10.3122/jabfm.2009.02.080035
Chizobam Ani
Charles Drew University of Medicine and Science, Los Angeles, CA (CA, MB, DH, RB)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohsen Bazargan
Charles Drew University of Medicine and Science, Los Angeles, CA (CA, MB, DH, RB)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Hindman
Charles Drew University of Medicine and Science, Los Angeles, CA (CA, MB, DH, RB)
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Bell
David Geffen School of Medicine, University of California-Los Angeles (DB, MR)
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Rodriguez
David Geffen School of Medicine, University of California-Los Angeles (DB, MR)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard S. Baker
Charles Drew University of Medicine and Science, Los Angeles, CA (CA, MB, DH, RB)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Characteristics of the Study Sample (n = 315)

    VariablesFrequency (n [%])
    Gender
        Male72 (22.9)
        Female243 (77.1)
    Age (years)
        18–4494 (29.8)
        45–54104 (33.0)
        ≥55117 (37.1)
        Mean age (SD)49.85 (10.80)
    Ethnicity
        Latino/Hispanic192 (61.0)
        Black/African-American71 (22.5)
        Other*52 (16.5)
    Health insurance status
        No health insurance coverage160 (50.7)
        Some source of health insurance155 (49.3)
    Medical visits during past 12 months (n)
        1177 (56.2)
        2–358 (18.4)
        ≥480 (25.4)
    Depression and chronic physical conditions
        Depression no chronic physical condition (CCI score = 0)86 (27.3)
        Depression and chronic physical condition (moderate CCI score = 1–2)106 (33.7)
        Depression and chronic physical Condition (severe CCI score ≥3)123 (39.0)
    Depression severity
        Moderate103 (32.7)
        Moderately severe131 (41.6)
        Severe81 (25.7)
    Physician depression diagnosis
        Not diagnosed207 (67.4)
        Diagnosed100 (32.6)
    Depression treatment‡
        Non–guideline-concordant212 (67.3)
        Guideline-Concordant103 (32.7)†
    Depression follow-up care‡
        Non–guideline-concordant236 (83.7)
        Guideline concordant46 (16.3)
    • ↵* “Others” here refer to whites, Asian-Americans, and all other ethnicities.

    • ↵† Included 3 patients without a documented diagnosis of depression.

    • ↵‡ Among all participants regardless of diagnosis status.

    • CCI, Charlson Comorbidity Index.

    • View popup
    Table 2.

    Bivariate Analysis Outcome and Independent Variable in Patients with Depression with No Chronic Physical Condition Vs Patients with Moderate Charlson Comorbidity Index (CCI) Score of 1 to 2 and Depression Vs Patients with a Severe Charlson Comorbidity Index Score of ≥3 and Depression

    VariablesDepression with No Chronic Condition (n [%])Depression with Chronic Condition(s)* (n [%])Depression with Chronic Condition(s)† (n [%])χ2 (P)
    Physician depression diagnosis0.130 (.937)
        Not diagnosed60 (27.9)72 (33.5)83 (38.6)
        Diagnosed26 (26.0)34 (34.0)40 (40.0)
    Depression treatment2.194 (.334)
        Non-guideline concordant25 (25.0)30 (30.0)45 (45.0)
        Guideline concordant61 (28.4)76 (35.3)78 (36.3)
    Depression follow-up care3.577 (.167)
        Non-guideline concordant54 (22.9)88 (37.3)94 (39.8)
        Guideline concordant15 (32.6)11 (23.9)20 (43.5)
    Depression everity2.562 (.634)
        Moderate33 (32.0)34 (33.0)36 (35.0)
        Moderately severe31 (23.7)47 (35.9)53 (40.5)
        Severe22 (27.2)25 (30.9)34 (42.0)
    Medical visits during past 12 months (n)7.239 (.124)
        158 (32.8)58 (32.8)61 (34.5)
        2–313 (12.4)21 (36.2)24 (41.4)
        ≥415 (18.8)27 (33.8)38 (47.5)
    Age (years)102.852‡ (<.001)
        18–4444 (46.8)41 (43.6)9 (9.6)
        45–5425 (24.0)50 (48.1)29 (27.9)
        ≥5517 (14.5)15 (12.8)85 (72.6)
    Ethnicity14.368§ (.006)
        Latino/Hispanic45 (23.4)66 (34.4)81 (42.2)
        Black/African-American16 (22.5)25 (35.2)50 (42.3)
        Other25 (48.1)15 (28.8)12 (23.1)
    Gender0.646 (.724)
        Male19 (26.4)27 (37.5)26 (36.1)
        Female67 (27.6)79 (32.5)97 (39.9)
    • ↵* Moderate CCI score = 1–2.

    • ↵† Severe CCI score = ≥3.

    • ↵‡ P <.050 is significant.

    • ↵§ P <.001 is significant.

    • View popup
    Table 3.

    Bivariate Analysis Outcome and Independent Variable in Patents with Depression with No Chronic Physical Condition vs Paitents with Chronic Physical Conditions (Charlson Comorbidity Index score ≥1) with Depression

    VariablesDepression with No Chronic Condition (n [%])Depression with Chronic Condition(s)* (n [%])χ2 (P)
    Physician dpression dagnosis0.125 (.724)
        Not dagnosed60 (69.8)155 (67.7)
        Diagnosed26 (30.2)74 (32.3)
    Deression treatment0.391 (.532)
        Non-guideline concordant61 (70.9)154 (67.2)
        Guideline concordant25 (29.1)75 (32.8)
    Depression follow-up care1.971 (.160)
        Non-guideline concordant54 (78.3)182 (85.4)
        Guideline concordant15 (21.7)31 (14.6)
    Depression severity2.039 (.361)
        Moderate33 (38.4)70 (30.6)
        Moderately severe31 (36.0)100 (43.7)
        Severe22 (25.6)59 (25.8)
    Medical visits during past 12 months (n)6.311 (.043)†
        158 (67.4)119 (52.0)
        2–313 (15.1)45 (19.7)
        ≥415 (17.4)65 (28.4)
    Age (years)28.195 (<.001)‡
        18–4444 (51.2)50 (21.8)
        45–5425 (29.1)79 (34.5)
         ≥5517 (19.8)100 (43.7)
    Ethnicity13.56 (.001)†
        Latino/Hispanic45 (53.3)147 (64.2)
        Black/African-American16 (18.6)55 (24.0)
        Other25 (29.1)27 (11.8)
    Gender0.039 (.843)
        Male19 (22.1)53 (23.1)
        Female67 (77.9)176 (22.9)
    • ↵* Charlson Comorbidity Index score ≥1.

    • ↵† P <.050 is significant.

    • ↵‡ P <.001 is significant.

    • View popup
    Table 4.

    Binary Logistic Regression: Physician Depression Diagnosis vs Independent Variables

    VariablesP*Unadjusted OR (95% CI)P†Adjusted OR (95% CI)
    Chronic medical condition
        No chronic medical condition; depression only (Ref)N/A1.00 (–)N/A1.00 (–)
        Depression with moderate CCI score of 1–2.7841.09 (0.59–2.02).481.26 (0.66–2.45)
        Depression with severe CCI score of ≥3.7261.11 (0.61–2.02).241.56 (0.74–3.31)
    Depression severity
        Moderate (Ref)N/A1.00 (–)N/A1.00 (–)
        Moderately severe.441.26 (0.70–2.25).4921.23 (0.68–2.22)
        Severe.012.25* (1.21–4.21).022.10* (1.11–3.98)
    Medical visits during past 12 months (n)
        1 (Ref)N/A1.00 (–)N/A1.00 (–)
        2–3.991.01 (0.53–1.88).900.98 (0.51–1.89)
        ≥4.520.83 (0.47–1.47).470.82 (0.42–1.48)
    Age (years)
        18–44 (Ref)N/A1.00 (–)N/A1.00 (–)
        45–54.521.21 (0.68–2.16).440.78 (0.41–1.47)
        ≥55.771.09 (0.62–1.93).230.63 (0.3–1.34)
    Gender
        Male (Ref)N/A1.00 (–)N/A1.00 (–)
        Female.161.53 (0.84–2.77).221.465 (0.793–2.706)
    Ethnicity
        Latino/Hispanic (Ref)N/A1.00 (–)N/A1.000 (–)
        African-American.220.67 (0.36–1.26).470.79 (0.42–1.49)
        Non–African-American and Others).110.54 (0.25–1.16).161.65 (0.83–3.29)
    −2 likelihood of final model = 380.6
    Nagelkerke R2 = 0.057
    • ↵* P <.050 is significant.

    • ↵† P <.001 is significant.

    • OR, odds ratio; CCI, Charlson Comorbidity Index; Ref, reference category.

    • View popup
    Table 5.

    Binary Logistic Regression: Guideline-Concordant Depression Care Vs Independent Variables*

    VariablesP†Unadjusted OR (95% CI)P‡Adjusted OR (95% CI)
    Chronic medical condition
        No chronic medical condition; depression only (Ref)N/A1.00 (–)N/A1.000 (–)
        Depression with moderate CCI score of 1–2.260.50 (0.15–1.67).560.65 (0.16–2.73)
        Depression with severe CCI score of ≥3.590.71 (0.21–2.40).410.54 (0.13–2.32)
    Depression Severity
        Moderate (Ref)N/A1.00 (–)N/A1.00 (–)
        Moderately severe.170.41 (0.12–1.45).130.34 (0.08–1.36)
        Severe.230.46 (0.13–1.66).180.38 (0.09–1.57)
    Total Number of Medical visits in past 12 months
        1 (Ref)N/A1.00 (–)N/A1.00 (–)
        2–3.260.50 (0.15–1.67).331.99 (0.50–7.85)
        ≥4.590.71 (0.21–2.40).960.97 (0.298–3.18)
    Age (years)
        18–44 (Ref)N/A1.00 (–)N/A1.00 (–)
        45–54.931.05 (0.37–3.00).900.93 (0.29–2.95)
        ≥55.182.20 (0.69–6.97).262.36 (0.53–10.58)
    Gender
        Male (Ref)N/A1.00 (–)N/A1.00 (–)
        Female.172.11 (0.72–6.20).102.82 (0.82–9.75)
    Ethnicity
        Latino/Hispanic (Ref)N/A1.00 (–)N/A1.00 (–)
        African-American.790.87 (0.28–2.62).780.83 (0.23–3.04)
        Non–African-American and Others.212.37 (0.62–9.11).421.82 (0.43–7.83)
    −2 log likelihood of final model = 0.146
    Nagelkerke R2 = 104.1
    • ↵* Participants with a physician diagnosis of depression = 100.

    • ↵† P <.050 is significant.

    • ↵‡ P <.001 is significant.

    • OR, odds ratio; Ref, reference category; CCI, Charlson Comorbidity Index.

    • View popup
    Table 6.

    Binary Logistic Regression: Guideline-Concordant Depression Follow-up Care vs Independent Variables*

    VariablesP†Unadjusted OR (95% CI)P‡Adjusted OR (95% CI)
    Chronic medical condition
        No chronic medical condition; depression only (Ref)N/A1.00 (–)N/A1.00 (–)
        Depression with chronic conditions (CCI score ≥1).160.41 (0.12–1.14).150.29 (0.06–1.49)
    Depression severity
        Moderate (Ref)N/A1.00 (–)N/A1.00 (–)
        Moderately severe.010.14* (0.03–0.60).010.11* (0.02–0.55)
        Severe.010.50* (0.01–0.42).010.04* (0.01–0.41)
    Age (years)
        18–44 (Ref)N/A1.00 (–)N/A1.00 (–)
        45–54.340.43 (0.08–2.43).460.44 (0.05–3.90)
        ≥55.781.20 (0.33–4.41).481.90 (0.31–10.93)
    Gender
        Male (Ref)N/A1.00 (–)N/A1.00 (–)
        Female.230.44 (0.12–1.66).560.60 (0.11–3.31)
    Ethnicity
        Latino/Hispanic (Ref)N/A1.00 (–)N/A1.00 (–)
        African-American.112.92 (0.79–10.81).352.22 (0.42–11.77)
        Non–African-American and Others.390.39 (0.05–3.39).150.16 (0.01–1.90)
    −2 log likelihood of final model = 51.0
    Nagelkerke R2 = 0.411
    • ↵* Participants with a physician diagnosis of depression = 100.

    • ↵† P <.050 is significant.

    • ↵‡ P <.001 is significant.

    • OR, odds ratio; CCI, Charlson Comorbidity Index; Ref, reference category.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 22 (2)
The Journal of the American Board of Family Medicine
Vol. 22, Issue 2
March-April 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comorbid Chronic Illness and the Diagnosis and Treatment of Depression in Safety Net Primary Care Settings
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comorbid Chronic Illness and the Diagnosis and Treatment of Depression in Safety Net Primary Care Settings
Chizobam Ani, Mohsen Bazargan, David Hindman, Douglas Bell, Michael Rodriguez, Richard S. Baker
The Journal of the American Board of Family Medicine Mar 2009, 22 (2) 123-135; DOI: 10.3122/jabfm.2009.02.080035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comorbid Chronic Illness and the Diagnosis and Treatment of Depression in Safety Net Primary Care Settings
Chizobam Ani, Mohsen Bazargan, David Hindman, Douglas Bell, Michael Rodriguez, Richard S. Baker
The Journal of the American Board of Family Medicine Mar 2009, 22 (2) 123-135; DOI: 10.3122/jabfm.2009.02.080035
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Objectives
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • TOP Docs: Family Physicians with Competing Demands and the Right Priorities—Individual, Family, and Community Health
  • PubMed
  • Google Scholar

Cited By...

  • The challenge of comorbidity in clinical trials for multiple sclerosis
  • The Role of Family Physicians in Mental Health Care Delivery in the United States: Implications for Health Reform
  • GPs good at ruling out depression in primary care, but false positives common
  • TOP Docs: Family Physicians with Competing Demands and the Right Priorities--Individual, Family, and Community Health
  • Google Scholar

More in this TOC Section

  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
  • Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
Show more Original Research

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire